Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study.
J Chemother. 2024 Mar 18:1-7. doi: 10.1080/1120009X.2024.2330835. Online ahead of print.
J Chemother. 2024.
PMID: 38497444
Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancer.
Kavgaci G, Dizdar O, Yalcin S.
Kavgaci G, et al.
Anticancer Drugs. 2024 Jun 1;35(5):459-461. doi: 10.1097/CAD.0000000000001587. Epub 2024 Mar 5.
Anticancer Drugs. 2024.
PMID: 38451823
Item in Clipboard
The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review.
Guven DC, Kavgaci G, Erul E, Syed MP, Magge T, Saeed A, Yalcin S, Sahin IH.
Guven DC, et al. Among authors: kavgaci g.
Oncologist. 2024 May 3;29(5):e580-e600. doi: 10.1093/oncolo/oyae013.
Oncologist. 2024.
PMID: 38309719
Free PMC article.
Item in Clipboard
Acute heart failure following pazopanib treatment: a literature review featuring two case reports.
Kertmen N, Kavgaci G, Yildirim HC, Dizdar O.
Kertmen N, et al. Among authors: kavgaci g.
Anticancer Drugs. 2024 Mar 1;35(3):302-304. doi: 10.1097/CAD.0000000000001560. Epub 2023 Nov 28.
Anticancer Drugs. 2024.
PMID: 38018812
Review.
Item in Clipboard
Advances in the Early Detection of Hepatobiliary Cancers.
Yıldırım HÇ, Kavgaci G, Chalabiyev E, Dizdar O.
Yıldırım HÇ, et al. Among authors: kavgaci g.
Cancers (Basel). 2023 Jul 30;15(15):3880. doi: 10.3390/cancers15153880.
Cancers (Basel). 2023.
PMID: 37568696
Free PMC article.
Review.
Item in Clipboard
The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors.
Guven DC, Ozbek DA, Sahin TK, Kavgaci G, Aksun MS, Erul E, Yildirim HC, Chalabiyev E, Cebroyilov C, Yildirim T, Dizdar O, Aksoy S, Yalcin S, Kilickap S, Erman M, Arici M.
Guven DC, et al. Among authors: kavgaci g.
Anticancer Drugs. 2023 Jul 1;34(6):783-790. doi: 10.1097/CAD.0000000000001463. Epub 2022 Dec 19.
Anticancer Drugs. 2023.
PMID: 36729111
Item in Clipboard
The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors.
Guven DC, Aktepe OH, Aksun MS, Sahin TK, Kavgaci G, Ucgul E, Cakir IY, Yildirim HC, Guner G, Akin S, Kertmen N, Dizdar O, Aksoy S, Erman M, Yalcin S, Kilickap S.
Guven DC, et al. Among authors: kavgaci g.
Cancer Biomark. 2022;34(2):189-199. doi: 10.3233/CBM-210349.
Cancer Biomark. 2022.
PMID: 34958005
Item in Clipboard
The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy.
Guven DC, Kavgaci G, Aktepe OH, Yildirim HC, Sahin TK, Aksoy S, Erman M, Kilickap S, Yalcin S.
Guven DC, et al. Among authors: kavgaci g.
J Oncol Pharm Pract. 2022 Jun;28(4):785-793. doi: 10.1177/10781552211012038. Epub 2021 Apr 20.
J Oncol Pharm Pract. 2022.
PMID: 33878976
Item in Clipboard
Cite
Cite